MethyLPREDNISolone Acetate Suspension Recalled for Temperature Abuse
Mckesson Medical-Surgical is recalling MethyLPREDNISolone Acetate Injectable Suspension due to temperature-abuse cGMP deviations affecting 363 vials distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for cGMP deviations involving temperature abuse of a prescription corticosteroid. No illnesses, adverse events, or injuries reported. Per the rubric, theoretical hazards without reported harm are scored at most 3.
Plain-English summary
Mckesson Medical-Surgical Inc. is recalling MethyLPREDNISolone Acetate Injectable Suspension, USP, 400 mg/10 mL vials (NDC 16714-090-01, manufactured by NorthstarRx/Teva Pharma USA) due to cGMP deviations involving temperature abuse. A total of 363 vials have been recalled.
The recalled product was distributed nationwide in the United States. Temperature abuse during storage or distribution may compromise product quality, stability, or sterility. No adverse events, illnesses, or injuries have been reported in connection with this recall.
Healthcare facilities and pharmacies that received affected vials should immediately cease use and contact Mckesson Medical-Surgical for product identification and return instructions. Because product lot numbers cannot be definitively identified by the distributor, the recall includes all potentially affected inventory from the specified distribution period.
Patients currently receiving this medication should not discontinue treatment without consulting their healthcare provider. Healthcare providers can contact the FDA or Mckesson Medical-Surgical for additional information regarding this recall.
The recalled product
- Product
- MethyLPREDNISolone Acetate Injectable Suspension, USP, 400 mg/10 mL (40 mg/mL), 10 mL Multiple Dose Vial, Rx only, MFG: NorthstarRx/Teva Pharma USA, NDC 16714-090-01
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Hazard
- Affected units
- 363
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 130 recalled by Mckesson Medical-Surgical Inc. Corporate Office under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 130 products in this recall →Related recalls
Same manufacturer · Mckesson Medical-Surgical Inc. Corporate Office
See all →- ModerateStrep A test kits recalled after shipment to unlicensed purchasing customers
FDA (Devices) · 2025-08-27
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateEvenity prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateBenlysta vials recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateAbbott Diagnostics ARC Carbon Dioxide Calibrator Cold Chain Storage Issue
FDA (Devices) · 2025-06-04
Same hazard · temperature abuse
See all →- ModerateGemcitabine Injection Recalled Due to Temperature Storage Abuse
FDA (Drugs) · 2026-07-08
- ModerateGarland Fresh peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- ModerateChristopher Ranch peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- SevereCrab Cakes Sold to Food Service Recalled for Botulism Risk
FDA (Food) · 2026-04-15
- CriticalUDENYCA syringes recalled after cartons were stored at room temperature
FDA (Drugs) · 2026-02-18